Brief: Matinas Biopharma Holdings Inc Keith Kucinski Resigns As CFO Effective January 17, 2026
Jan 23 (Reuters) - Matinas BioPharma Holdings Inc MTNB.A: MATINAS BIOPHARMA HOLDINGS INC - KEITH KUCINSKI RESIGNS AS CFO EFFECTIVE JANUARY 17, 2026 - SEC FILING MATINAS BIOPHARMA HOLDINGS INC - JEROME D. JABBOUR APPOINTED INTERIM CFO EFFECTIVE JANUARY 22, 2026 - SEC FILING Source text: [ID:n0001493152-26-003445] Further company coverage: MTNB.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Matinas BioPharma Holdings
See all newsBrief: Matinas Biopharma - May Offer Securities Up To $150 Million - SEC Filing
Brief: Matinas Biopharma Holdings Inc Keith Kucinski Resigns As CFO Effective January 17, 2026
Brief: Matinas Biopharma Holdings Inc - CFO Keith Kucinski Resigns Effective January 17, 2026 - SEC Filing
Brief: Matinas Biopharma Holdings Eric Ende Resigns As Chairman Of Matinas Biopharma
Brief: Matinas BioPharma Appoints Seasoned Biotech Leaders To Board Of Directors